MicrobiomeTrials
  • Search Trials
  • Conditions
  • Learn
  • About
Data source: ClinicalTrials.gov
This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Sign up for updates
Loading filters…
Showing 271 trials for Ulcerative Colitis
AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative ColitisRecruiting
Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Colitis
This Phase 2b randomized, double-blind, placebo-controlled, multicenter trial will evaluate the efficacy and safety of a…
Izmir, Turkey (Türkiye)Est. completion May 30, 2027
View Trial →
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisPhase 2Recruiting
Ulcerative ColitisInflammatory Bowel DiseasesColitisColitis, Ulcerative
This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active…
Canoga Park, United StatesEst. completion Jun 2026
View Trial →
A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative ColitisPhase 1Recruiting
Moderate to Severe Ulcerative Colitis
This study aims to evaluate the pharmacodynamic (PD) effects of vixarelimab in the gut of participants with active moder…
Berlin, GermanyEst. completion Jul 9, 2026
View Trial →
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative ColitisPhase 3Recruiting
Colitis, Ulcerative
The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to…
Anaheim, United StatesEst. completion Aug 11, 2028
View Trial →
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative ColitisPhase 2Recruiting
Ulcerative Colitis
The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment…
Little Rock, United StatesEst. completion Jun 16, 2029
View Trial →
A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy AdultPhase 1Recruiting
Ulcerative Colitis (UC)Ulcerative Colitis (Disorder)Ulcerative Colitis AcuteIBD (Inflammatory Bowel Disease)CD - Crohn's Disease
A Phase 1, 2-part, randomised, double-blind, placebo-controlled, FIH study to determine the safety, tolerability, and PK…
Hangzhou, ChinaEst. completion Dec 31, 2026
View Trial →
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)Recruiting
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lin…
Harrow, United KingdomEst. completion Mar 5, 2029
View Trial →
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative ColitisPhase 3Recruiting
Colitis, Ulcerative
The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinr…
Chandler, United StatesEst. completion Jan 14, 2028
View Trial →
Immune Regulation in Ulcerative Colitis or Crohn s DiseaseRecruiting
Inflammatory Bowel DiseaseUlcerative ColitisChrohn's Disease
This study will investigate in patients with Crohn s disease and ulcerative colitis how the body s immune system control…
Bethesda, United States
View Trial →
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative ColitisRecruiting
Colitis, Ulcerative
The purpose of this study is to assess the measurable changes in health, function, or quality of life (clinical outcomes…
Beijing, ChinaEst. completion Jun 30, 2028
View Trial →
Personalized Anti-Inflammatory Fibres in Ulcerative ColitisRecruiting
Ulcerative Colitis
The goal of this clinical trial is to determine the clinical effects of two different dietary fibre supplements, acacia …
Edmonton, CanadaEst. completion Dec 2027
View Trial →
A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in GermanyRecruiting
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
The purpose of this study is to characterize participants with Crohn's Disease (CD) and Ulcerative Colitis (UC) treated …
Berlin, GermanyEst. completion Jan 15, 2029
View Trial →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative ColitisPhase 3Recruiting
Ulcerative Colitis
Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of…
Phoenix, United StatesEst. completion Jul 2034
View Trial →
The Use of Butyrate Therapy in Pediatric Ulcerative ColitisPhase 2Recruiting
Ulcerative Colitis
Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative…
Los Angeles, United StatesEst. completion Jun 30, 2027
View Trial →
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseasePhase 2Recruiting
Colitis, UlcerativeCrohn Disease
Study IIBD is a master protocol that will support a collection of individual sub studies that share key design component…
Scottsdale, United StatesEst. completion Jun 2027
View Trial →
Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis PopulationPhase 1Recruiting
Ulcerative ColitisInflammatory Bowel DiseasesClostridioides Difficile Infection
This is a multi-centre, randomised controlled trial comparing fecal microbiota transplantation to placebo in an expanded…
Calgary, CanadaEst. completion Mar 1, 2028
View Trial →
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:Phase 2Recruiting
Ulcerative Colitis
The main purpose of the study is to evaluate the effectiveness and safety of LY4268989 when given with mirikizumab compa…
Scottsdale, United StatesEst. completion May 2027
View Trial →
LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisPhase 2Recruiting
Ulcerative Colitis (UC)Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
The main purpose of this study is to evaluate the safety and effectiveness of LY4268989 when compared to placebo in adul…
Phoenix, United StatesEst. completion Jun 2030
View Trial →
Confirmatory Clinical Study in Active Ulcerative ColitisPhase 2Recruiting
Colitis, Ulcerative
The main goal of the study is to check if MH002 works and is safe to use. In a previous study in 45 patients with Ulcera…
Miami, United StatesEst. completion Sep 2027
View Trial →
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)Phase 3Recruiting
Ulcerative ColitisUlcerative Colitis ChronicInflammatory Bowel DiseasesCrohn's Disease
The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcer…
San Francisco, United StatesEst. completion Dec 2030
View Trial →
← PreviousPage 1 of 14Next →
Recruitment Status